Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004842 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
A Phase 1 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT00004842 is a Phase 1 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 22 participants.
The verdict
NCT00004842, a Phase 1 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Assess the safety and effectiveness of budesonide in patients with primary sclerosing cholangitis or primary biliary cirrhosis experiencing a suboptimal response to ursodeoxycholic acid. II. Estimate the efficacy of this therapy in these patient groups as a means of evaluating the feasibility of a long-term randomized trial.
Interventions
- DRUG budesonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 1997-05 |
| Est. Completion | 1999-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004842
The ClinicalTrials.gov registry entry for NCT00004842 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which budesonide is the first listed.
NCT00004842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004842 about?
NCT00004842 is a clinical study titled "Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis". OBJECTIVES: I. Assess the safety and effectiveness of budesonide in patients with primary sclerosing cholangitis or primary biliary cirrhosis experiencing a suboptimal response to ursodeoxycholic acid. II. Estimate the efficacy of this therapy in these patient groups as a means of evaluating the fe...
What is the current status of trial NCT00004842?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 1997-05. Estimated completion is 1999-04.
What interventions are being tested in trial NCT00004842?
The interventions under investigation include: budesonide (DRUG).
Who is sponsoring clinical trial NCT00004842?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.